Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06428448

Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections

This study is being conducted to evaluate the safety and effectiveness of the REMEDY SPECTRUM IM Spacer Nail in the treatment of ankle-related infections. The study is expected to take approximately 18 months from first subject enrolled to the last follow-up visit. It will have a 12-month enrollment period and a 6-month follow-up. This study is a Prospective, multicenter, single-arm clinical trial. All subjects enrolled in this study will receive the REMEDY SPECTRUM IM Spacer Nail.

Recruiting

Interested in participating?

Request Info

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Michigan Health - Sparrow Clinical Research Institute, Lansing, Michigan, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be ≥ 21 years of age
  • Have an ankle-related infection
  • Is skeletally mature, as evidenced by closed epiphyses.
  • Be able to give voluntary, written informed consent to participate and have signed an Informed Consent Form specific to this study
  • Be willing and able to comply with all study procedures including all pre-operative, post-operative requirements
  • If female and of child-bearing potential, must have a negative pregnancy test prior to the surgical procedure and no intention of becoming pregnant until study completion.

Exclusion criteria

  • Infections that do not involve the ankle
  • Have a known immunodeficiency; including subjects who are receiving or have received immunosuppressants, immunostimulating agents or radiation therapy within 6 months prior to surgery
  • Affected limb is dysvascular
  • Where adequate soft-tissue coverage cannot be achieved
  • Have any mental or psychological disorder that would impair their ability to complete the study questionnaires
  • Are currently pregnant or breastfeeding, or planning to become pregnant or breastfeed any time during the course of the study
  • Are currently a prisoner
  • Have any medical condition or other circumstances, in the judgment of the Investigator, that might interfere with the ability to return for follow-up visits, including any systemic illness, neuromuscular, neurosensory, or musculoskeletal deficiency that would render the subject unable to perform appropriate post-operative activities.
  • History of vancomycin or gentamicin allergy
  • Are implanted with other antibiotic eluting products.

Treatment and study plan

REMEDY Spectrum IM Spacer Nail

Combination Product

The REMEDY SPECTRUM IM Spacer Nail is a single-use implant made of polymethylmethacrylate (PMMA) which is internally reinforced with a stainless-steel core (ASTM F138, ISO 5832-1). The PMMA of the REMEDY SPECTRUM IM Spacer Nail is laden with gentamicin and vancomycin.

The nail has a slot at the distal end and can be combined with the surgeon's choice of fixation to prevent migration depending on the anatomy of the patient. The REMEDY SPECTRUM IM Spacer Nail is available in two lengths (150mm and 300mm) to accommodate variations in patient anatomy. The distal end has a threaded recess for mating with the optional distal cap, as well as the insertion and removal tools.

Primary outcomes

  1. Successful Treatment of Infection Based on Lab Values and Culture

    Time frame: 6 months

    Healed wound and no infection recurrence caused by the same organism strain infection for duration of two weeks post antibiotic regimen.

Study contacts

Contact information is provided by the study sponsor or research team.

Crystal Djaba

CONTACT

[email protected]

470-736-7850

Jacob Schafer

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

OsteoRemedies, LLC

Industry

Collaborators

  • MCRA

Registry information

Official study title

A Prospective, Multi-Center Study to Evaluate the Safety and Effectiveness of the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
May 24, 2024
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.